319 related articles for article (PubMed ID: 35573993)
1. The Evaluation of Ovarian Function Recovery Following Treatment of Primary Ovarian Insufficiency: A Systematic Review.
Kuang X; Tang Y; Xu H; Ji M; Lai D
Front Endocrinol (Lausanne); 2022; 13():855992. PubMed ID: 35573993
[TBL] [Abstract][Full Text] [Related]
2. The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
Wong QHY; Yeung TWY; Yung SSF; Ko JKY; Li HWR; Ng EHY
J Assist Reprod Genet; 2018 May; 35(5):857-862. PubMed ID: 29520734
[TBL] [Abstract][Full Text] [Related]
3. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review.
Anderson RA; Cameron D; Clatot F; Demeestere I; Lambertini M; Nelson SM; Peccatori F
Hum Reprod Update; 2022 May; 28(3):417-434. PubMed ID: 35199161
[TBL] [Abstract][Full Text] [Related]
4. Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.
Cai Y; Zhang Q; Yu K; Wang Q
Biomed Res Int; 2022; 2022():3878359. PubMed ID: 36277874
[TBL] [Abstract][Full Text] [Related]
5. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.
Aflatoonian A; Lotfi M; Saeed L; Tabibnejad N
Reprod Sci; 2021 Jul; 28(7):2050-2059. PubMed ID: 33683669
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.
Vahabi Dastjerdi M; Sheibani S; Taheri M; Hezarcheshmeh FK; Jahangirian J; Jazayeri M; Hosseinirad H; Doohandeh T; Valizadeh R
Arch Gynecol Obstet; 2024 Jun; 309(6):2323-2338. PubMed ID: 38589612
[TBL] [Abstract][Full Text] [Related]
7. Stem cell therapy for premature ovarian insufficiency: a systematic review and meta-analysis of animal and clinical studies.
Hu L; Tan R; He Y; Wang H; Pu D; Wu J
Arch Gynecol Obstet; 2024 Feb; 309(2):457-467. PubMed ID: 37264272
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.
Jiao X; Meng T; Zhai Y; Zhao L; Luo W; Liu P; Qin Y
Front Endocrinol (Lausanne); 2021; 12():601752. PubMed ID: 33815272
[TBL] [Abstract][Full Text] [Related]
9. A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
Yeung TW; Li RH; Lee VC; Ho PC; Ng EH
J Clin Endocrinol Metab; 2013 Jan; 98(1):380-8. PubMed ID: 23144466
[TBL] [Abstract][Full Text] [Related]
10. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
[TBL] [Abstract][Full Text] [Related]
11. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
[TBL] [Abstract][Full Text] [Related]
12. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency.
Cakiroglu Y; Saltik A; Yuceturk A; Karaosmanoglu O; Kopuk SY; Scott RT; Tiras B; Seli E
Aging (Albany NY); 2020 Jun; 12(11):10211-10222. PubMed ID: 32507764
[TBL] [Abstract][Full Text] [Related]
13. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
14. The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.
Li X; Liu H; Lin G; Xu L
Front Endocrinol (Lausanne); 2023; 14():1292168. PubMed ID: 38155954
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human.
Mashayekhi M; Mirzadeh E; Chekini Z; Ahmadi F; Eftekhari-Yazdi P; Vesali S; Madani T; Aghdami N
J Ovarian Res; 2021 Jan; 14(1):5. PubMed ID: 33407794
[TBL] [Abstract][Full Text] [Related]
16. Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review.
Drechsel KCE; Pilon MCF; Stoutjesdijk F; Meivis S; Schoonmade LJ; Wallace WHB; van Dulmen-den Broeder E; Beishuizen A; Kaspers GJL; Broer SL; Veening MA
Hum Reprod Update; 2023 Jul; 29(4):486-517. PubMed ID: 36779325
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
18. Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women.
Sfakianoudis K; Simopoulou M; Grigoriadis S; Pantou A; Tsioulou P; Maziotis E; Rapani A; Giannelou P; Nitsos N; Kokkali G; Koutsilieris M; Pantos K
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32532000
[TBL] [Abstract][Full Text] [Related]
19. Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis.
Éliás M; Kónya M; Kekk Z; Turan C; das Virgens IPA; Tóth R; Keszthelyi M; Hegyi P; Várbíró S; Sipos M
J Ovarian Res; 2024 May; 17(1):104. PubMed ID: 38760869
[TBL] [Abstract][Full Text] [Related]
20. Menstrual cycle characteristics of young females with occult primary ovarian insufficiency at initial diagnosis and one-year follow-up with serum amh level and antral follicle count.
Guzel Y; Aba YA; Yakin K; Oktem O
PLoS One; 2017; 12(11):e0188334. PubMed ID: 29176793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
